Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1900-2024Class II

Brand Name: EsophaCap Product Name: EsophaCap (25mm diameter, 10 pores/inch) Model/Catalog Number: EC25T10VI...

Lucid Diagnostics, Inc. / initiated 2024-04-24 / Open, Classified

Lucid Diagnostics, Inc. began a recall of Brand Name: EsophaCap Product Name: EsophaCap (25mm diameter, 10 pores/inch) Model/Catalog Number: EC25T10VI Software Version: N/A Product Description... on . FDA classified it as Class II and gives the reason as "The EsophaCap sponge may be at increased risk of detaching from the string during removal of the device from the patient, particularly at the lower esophageal sphincter at the gastroesophageal junction or the upper...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1900-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Lucid Diagnostics, Inc.
Product
Brand Name: EsophaCap Product Name: EsophaCap (25mm diameter, 10 pores/inch) Model/Catalog Number: EC25T10VI Software Version: N/A Product Description: EsophaCap is pouched as individual units. 10 units go into a shelf-box. Component: N/A
Product code
EOX Esophagoscope (Flexible Or Rigid)
Reason for recall
The EsophaCap sponge may be at increased risk of detaching from the string during removal of the device from the patient, particularly at the lower esophageal sphincter at the gastroesophageal junction or the upper esophageal sphincter between the pharynx and the esophagus, which is the narrowest part of the alimentary canal.
FDA root cause
Under Investigation by firm
Action
On April 24, 2024 direct customers were sent notification letters via email with recall instructions. Effectiveness Checks: The signed Acknowledgment and Receipt forms must be returned along with any product that is still in-hand at the clinical sites. Customer Follow-up: Follow-ups will be conducted via phone and email for customers who do not respond. Returned Product: Returned product will be put into quarantine until all recalled product is under our control. Access is limited to authorized personnel only. It will then be destroyed. Destruction: Devices will be cut and disposed of. Once the string is cut, the device will no longer be functional to use. PD1 Quarantined: 115 PD2 Quarantined: 99 Preventive Action Taken by Firm: All EsophaCap product in the field will be returned to Lucid Diagnostics. The EsophaCap product is no longer manufactured for the clinical studies. The last manufactured product was February 2023.
Quantity in commerce
220 units (US)
Distribution
US Nationwide distribution in the states of MN, MD.
Product codes and lots
Lot Code: Product sent out to clinical site: Part #: EC25T10VI ; GTIN Number: 00860007510977 ; Lot #'s: 483 (Qty: 120), 502 (Qty: 100) Product at Distributor in Quarantine: Part #: EC25T10VI ; GTIN Number: 00860007510977 ; Lot #'s: 539 (Qty: 99)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1900-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1899-2024Class IIOngoingVoluntary: Firm initiated
Z-1900-2024Class IIOngoingVoluntary: Firm initiated